This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Ontario Health Technology Advisory Committee. OHTAC recommendation: photoselective vaporization for the treatment of benign prostatic hyperplasia. Toronto: Health Quality Ontario (HQO). OHTAC recommendation. 2013
Based on the earlier analysis from the Medical Advisory Secretariat on "Energy Delivery Systems for
Treatment of Benign Prostatic Hyperplasia" and further evidence from the subsequent field evaluation
study, OHTAC makes the following recommendations:
- Photoselective laser vaporization for benign prostatic hyperplasia is an effective, safe, and
cost-effective alternative to transurethral resection of the prostate (TURP) and may be
increasingly preferred over TURP because it can be performed in the outpatient setting, with
less blood loss and a reduced need for hospital admission.
- Appropriate diffusion of this technology will require training programs for urologists to
develop the necessary skills to perform the procedure.
Subject indexing assigned by CRD
Humans; Laser Therapy; Prostatic Hyperplasia
Country of organisation
An English language summary is available.
Address for correspondence
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5 Email: EDSinfo@hqontario.ca
Date abstract record published